Cargando…
Targeting the integrated stress response in hematologic malignancies
While numerous targeted therapies have been recently adopted to improve the treatment of hematologic malignancies, acquired or intrinsic resistance poses a significant obstacle to their efficacy. Thus, there is increasing need to identify novel, targetable pathways to further improve therapy for the...
Autores principales: | Nwosu, Gus O., Powell, Jason A., Pitson, Stuart M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644628/ https://www.ncbi.nlm.nih.gov/pubmed/36348393 http://dx.doi.org/10.1186/s40164-022-00348-0 |
Ejemplares similares
-
Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies
por: Lewis, Alexander C., et al.
Publicado: (2018) -
Author Correction: Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies
por: Lewis, Alexander C., et al.
Publicado: (2021) -
Targeting immune checkpoints in hematological malignancies
por: Salik, Basit, et al.
Publicado: (2020) -
Modification of the tumour microenvironment via exosomal shedding of sphingosine 1-phosphate receptor 2 by breast cancer cells
por: Pitson, Stuart M., et al.
Publicado: (2018) -
Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor
resistance in acute myeloid leukemia
por: Lewis, Alexander C., et al.
Publicado: (2022)